Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.19% | -0.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.19% | -0.90% | |||
| Cost of Revenue | 5.95% | 0.64% | |||
| Gross Profit | 70.69% | -9.23% | |||
| SG&A Expenses | 10.89% | 0.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.04% | 0.52% | |||
| Operating Income | 74.87% | -17.42% | |||
| Income Before Tax | 68.40% | -17.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 68.40% | -17.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.40% | -17.49% | |||
| EBIT | 74.87% | -17.42% | |||
| EBITDA | 114.23% | -32.32% | |||
| EPS Basic | 71.05% | -1.67% | |||
| Normalized Basic EPS | 67.62% | -11.31% | |||
| EPS Diluted | 70.00% | 0.00% | |||
| Normalized Diluted EPS | 67.62% | -11.31% | |||
| Average Basic Shares Outstanding | 9.38% | 4.99% | |||
| Average Diluted Shares Outstanding | 9.38% | 4.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||